Lexicon Pharmaceuticals LXRX Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's investment purchases?
- Lexicon Pharmaceuticals (LXRX) reported investment purchases of $105.96M in Q1 2026.
- How has Lexicon Pharmaceuticals's investment purchases changed year-over-year?
- Lexicon Pharmaceuticals's investment purchases increased by 63.1% year-over-year, from $64.97M to $105.96M.
- What is the long-term trend for Lexicon Pharmaceuticals's investment purchases?
- Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's investment purchases has grown at a 42.1% compound annual growth rate (CAGR), from $34.26M to $139.84M.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.